Louay Zeid
Obstetrics & Gynecology · Houston, TXNPI 1407087430
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $971 and has fallen 82.9% since, to $166 in 2025.
Across 224 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$992
- Sumitomo Pharma America, Inc.$320
- Myovant Sciences Inc.$285
- Lupin Inc.$279
- Pfizer$279
- Mayne Pharma Commercial LLC$269
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,480100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 53 | $992 |
| Sumitomo Pharma America, Inc. | 17 | $320 |
| Myovant Sciences Inc. | 13 | $285 |
| Lupin Inc. | 14 | $279 |
| Pfizer | 18 | $279 |
| Mayne Pharma Commercial LLC | 11 | $269 |
| Bayer | 11 | $239 |
| Coopersurgical, Inc. | 9 | $238 |
| Evofem Biosciences, Inc. | 12 | $188 |
| Avion Pharmaceuticals | 11 | $188 |
| Therapeuticsmd, Inc. | 4 | $142 |
| Exeltis, USA Inc. | 7 | $137 |
| Baxter Healthcare | 1 | $119 |
| Agile Therapeutics, Inc. | 7 | $119 |
| Merck | 6 | $105 |
| Organon | 5 | $99 |
| Myriad Genetic Laboratories, Inc. | 3 | $69 |
| Hologic Sales And Service, LLC | 4 | $64 |
| Astellas Pharma US Inc | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Aspira Women's Health Inc | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Inari Medical, Inc. | 1 | $25 |
| Harmony Biosciences LLC | 1 | $25 |
| Exact Sciences | 1 | $23 |
| Amgen | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $17 |
| Acessa Health Inc. | 1 | $15 |
| Optumhealth Care Solutions, LLC | 1 | $15 |
| Eisai Inc. | 1 | $13 |
| Novo Nordisk | 1 | $13 |
| Mission Pharmacal Company | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,487 in reported general payments places this provider in the 80th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 11 | $248 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Houston
- George KuhnHouston$244K
- Daisy AyimHouston$188K
- Shannon WestinHouston$176K
- Asha BhalwalHouston$151K
- Nicole TranHouston$133K
- Sandra HurtadoHouston$123K
- Alvaro MontealegreHouston$92K
- Patti RossHouston$72K
- Damla KarsanHouston$58K
- Christopher JayneHouston$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.